This blog gathers short articles written by ImVitro’s team members to share their insights about IVF but more generally about medtech and what it takes to deliver a medically compliant AI-driven SaaS platform!

Our aim is to provide uniquely curated information about IVF for people to better grasp what it entails, whether you are a doctor, a patient, or someone who knows an IVF patient. When you know that at least one out of 7 couples have infertility issues, you realize that it could be essentially most people (at least of reproductive age!)

Every blog post is reviewed by the company’s CEO. Nevertheless, the views expressed by the authors of these blog posts are solely their own current opinions and are based on their own perspective. Such views, opinions, and/or perspectives are not intended to malign any individual, religion, ethnic group, or company. The views and opinions expressed do not reflect the views of any third-party company or investment fund with which any author or ImVitro is, or may be, affiliated.

Click on the titles below the images to read the text!


IVF: Femtech or Famtech?

November 6th 2022, Alexandra Boussommier

Why serverless? An insight from ImVitro’s technical architect 

Sept 19, 2022, Hedaia Ghannam


5 tips for AI start-ups to effectively complete and maintain their CE marking technical file

May 9, 2022, Inès D’Heygère


The IVF journey part II: what happens after embryo transfer

April 19, 2022, Yakup Yilmaz

The IVF journey part I: what happens before embryo transfer

April 4, 2022, Yakup Yilmaz

Birth of ImVitro

March 21, 2022, Boussommier-Calleja Alexandra